833a – Efficacy in Biologic-Failure and Nonbiologic-Failure Populations in a Phase 3 Study of Ustekinumab in Moderatesevere Ulcerative Colitis: Unifi
Sands, Bruce E., Peyrin-Biroulet, Laurent, Marano, Colleen W., O'Brien, Christopher D., Zhang, Hongyan, Johanns, Jewel, Szapary, Philippe, Rowbotham, David, Leong, Rupert W., Arasaradnam, Ramesh, DaneVolume:
156
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(19)37242-7
Date:
May, 2019
File:
PDF, 3.10 MB
english, 2019